SCHEMBL22940945

SCHEMBL22940945

c1ncn(C2CCCCCCCCC2)c1C1CCCCCCCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 6/20 0.42
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
TDO2 P48775 4/20 0.36
PI4KA P42356 3/20 0.36
PI4K2B Q8TCG2 3/20 0.36
PI4K2A Q9BTU6 3/20 0.36
PI4KB Q9UBF8 3/20 0.36
ADORA2A P29274 2/20 0.36
LCK P06239 1/20 0.36
CYP11B2 P19099 1/20 0.35
HCAR1 Q9BXC0 3/20 0.34
AURKA O14965 1/20 0.34
JAK2 O60674 1/20 0.34
PRKCA P17252 1/20 0.34
JAK1 P23458 1/20 0.34
KDR P35968 1/20 0.34
JAK3 P52333 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1184926 1.00 IDO1 (0.42) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL22939918 1.00 IDO1 (0.42) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL22940947 1.00 IDO1 (0.42) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL2262558 0.74 IDO1 (0.43) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL2262566 0.74 HSP90AA1 (0.46) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL29201011 0.74 PI4KA (0.44) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL17571953 0.74 MAP4K4 (0.42) IDO1TDO2LCKCYP11B2
SCHEMBL5670454 0.74 TP53 (0.44)
SCHEMBL29200940 0.72 ADORA2A (0.42) IDO1HSP90AA1HSP90AB1TDO2PI4KA
SCHEMBL11397041 0.72 IDO1 (0.44) IDO1HSP90AA1HSP90AB1TDO2PI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584745-B2 Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2023-02-21 US disclosed
US-20210032241-A1 AROMATIC HETEROCYCLIC COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210032241-A1 AROMATIC HETEROCYCLIC COMPOUND, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF ALK, NOTUM, WEE1 IDO1 833/4885HSP90AA1 4691/4885HSP90AB1 4694/4885
US-11584745-B2 Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereof ALK, NOTUM, WEE1 IDO1 833/4885HSP90AA1 4691/4885HSP90AB1 4694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.